Next Article in Journal
Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease
Next Article in Special Issue
Elucidating the Effects of Curcumin against Influenza Using In Silico and In Vitro Approaches
Previous Article in Journal
Facilitation of TRKB Activation by the Angiotensin II Receptor Type-2 (AT2R) Agonist C21
Previous Article in Special Issue
Reynoutria Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors–Molecular Docking and In Vitro Study
 
 
Review

Article Versions Notes

Pharmaceuticals 2021, 14(8), 774; https://doi.org/10.3390/ph14080774
Action Date Notes Link
article pdf uploaded. 6 August 2021 14:46 CEST Version of Record https://www.mdpi.com/1424-8247/14/8/774/pdf-vor
article pdf uploaded. 6 August 2021 14:48 CEST Updated version of record https://www.mdpi.com/1424-8247/14/8/774/pdf-vor
article xml file uploaded 9 August 2021 10:40 CEST Original file -
article xml uploaded. 9 August 2021 10:40 CEST Update -
article pdf uploaded. 9 August 2021 10:40 CEST Updated version of record https://www.mdpi.com/1424-8247/14/8/774/pdf-vor
article html file updated 9 August 2021 10:41 CEST Original file -
article xml file uploaded 9 August 2021 10:49 CEST Update -
article xml uploaded. 9 August 2021 10:49 CEST Update https://www.mdpi.com/1424-8247/14/8/774/xml
article pdf uploaded. 9 August 2021 10:49 CEST Updated version of record https://www.mdpi.com/1424-8247/14/8/774/pdf
article html file updated 9 August 2021 10:51 CEST Update -
article html file updated 27 July 2022 08:34 CEST Update https://www.mdpi.com/1424-8247/14/8/774/html
Back to TopTop